BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Nature
Volume 595 Issue 7868, 22 July 2021
https://www.nature.com/nature/volumes/595/issues/7868

 

Article | 27 May 2021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
In a phase-I/II trial in healthy adults, the BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells against SARS-CoV-2 epitopes that are conserved in a wide range of currently circulating variants.
Ugur Sahin, Alexander Muik…Özlem Türeci